COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,761 Articles (22,502 medRxiv, 8,259 bioRxiv)

Most recent first Previous |  Page 1812: Articles 18111-18120  | Next

Colder and drier winter conditions are associated with greater SARS-CoV-2 transmission: a regional study of the first epidemic wave in north-west hemisphere countries.
Landier, J., Paireau, J., Rebaudet, S., Legendre, E., Le Hot, L., Fontanet, A., CAUCHEMEZ, S., Gaudart, J.
10.1101/2021.01.26.21250475 — Posted: 2021-01-26
Home-based management of COVID-19 by identification of low-risk features
Cabanillas, F., Morales, J., Bertran-Pasarell, J., Fernandez, R., Conde, J. G., Hernandez-Silva, Y., Liboy, I.
10.1101/2021.01.25.21249684 — Posted: 2021-01-26
Elevated HScore is Associated with Poor Clinical Outcomes in COVID-19, Even in the Absence of Secondary Hemophagocytic Lymphohistiocytosis.
Benavente, R., Pena, C., Cid, A., Cabello, N., Bustamante, P., Alvarez, M., Henriquez, E., Soto, A., Rubilar, E.
10.1101/2021.01.26.21249335 — Posted: 2021-01-26
Impact of social restrictions during the COVID-19 pandemic on the physical activity levels of older adults: an analysis of the CHARIOT COVID-19 Rapid Response Study
Salman, D., Beaney, T., Robb, C., Loots, C. A. d. J., Giannakopoulou, P., Udeh-Momoh, C., Ahmadi-Abhari, S., Majeed, A., Middleton, L. T., McGregor, A. H.
10.1101/2021.01.26.21250520 — Posted: 2021-01-26
Health impact of routine immunisation service disruptions and mass vaccination campaign suspensions caused by the COVID-19 pandemic: Multimodel comparative analysis of disruption scenarios for measles, meningococcal A, and yellow fever vaccination in 10 low- and lower middle-income countries
Gaythorpe, K., Abbas, K., Huber, J., Karachaliou, A., Thakkar, N., Woodruff, K., Li, X., Echeverria-Londono, S., VIMC Working Group on COVID-19 Impact on Vaccine Preventable Disease, , Ferrari, M., Jackson, M. L., McCarthy, K., Perkins, A., Trotter, C., Jit, M.
10.1101/2021.01.25.21250489 — Posted: 2021-01-26
Community structured model for vaccine strategies to control COVID19 spread: a mathematical study
Aruffo, E., Yuan, P., Tan, Y., Gatov, E., Gournis, E., Collier, S., Ogden, N., Bélair, J., Zhu, H.
10.1101/2021.01.25.21250505 — Posted: 2021-01-26
Estimation of the SARS-CoV-2 infection fatality rate in Germany
Dimpfl, T., Sönksen, J., Bechmann, I., Grammig, J.
10.1101/2021.01.26.21250507 — Posted: 2021-01-26
Emergence and fast spread of B.1.1.7 lineage in Lebanon.
younes, m., hamze, k., nassar, h., makki, m., Ghaddar, M., Nguewa, p., abdel sater, f.
10.1101/2021.01.25.21249974 — Posted: 2021-01-26
Logistic advantage of two-step screening strategy for SARS-CoV-2 at airport quarantine
Yokota, I., Shane, P. Y., Teshima, T.
10.1101/2021.01.25.21250509 — Posted: 2021-01-26
Covid-19 in end-stage renal disease patients with renal replacement therapies: a systematic review and meta-analysis
Nopsopon, T., Kittrakulrat, J., Takkavatakarn, K., Eiamsitrakoon, T., Kanjanabuch, T., Pongpirul, K.
10.1101/2021.01.25.21250454 — Posted: 2021-01-26

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).